At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
TearCaredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study of TearCare System - Long-Term Extension
In Brief
A clinical study evaluating TearCare for Dry Eye Syndromes. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The objective of the study is to evaluate the long-term clinical utility, safety, and effectiveness of re-treatment with the TearCare™ System in adult patients with dry eye syndrome who had previously been treated with the TearCare System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedJan 2019
Primary CompletionMay 2019
TodayJul 2026
First PostedJan 15, 2019
Enrollment StartDec 17, 2018
Primary CompletionMay 21, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.5 years ago
Interventions
TearCaredevice
The TearCare System warms the eyelids to melt the meibum by applying heat to the external surface of the eyelids for 15 minutes. Following completion of the thermal portion of the procedure, the clinician performs manual expression of each of the eyelids.